Neurocrine Biosciences, Inc. (BIT:1NBIX)
Italy · Delayed Price · Currency is EUR 115.40
+2.40 (2.12%)
At close: Jan 21, 2026
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of €11.54 billion as of January 22, 2026. Its market cap has decreased by -15.03% in one year.
Market Cap
11.54B
Enterprise Value
11.00B
Revenue
2.29B
Ranking
n/a
PE Ratio
31.64
Stock Price
€115.40
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 167.33M to 11.54B, an increase of 6,798.52%. That is a compound annual growth rate of 15.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 11.54B | -4.16% |
| Dec 31, 2025 | 12.04B | -9.77% |
| Dec 31, 2024 | 13.35B | 13.98% |
| Dec 29, 2023 | 11.71B | 9.01% |
| Dec 30, 2022 | 10.74B | 51.23% |
| Dec 31, 2021 | 7.10B | -2.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Banca Mediolanum | 14.10B |
| Mediobanca Banca di Credito Finanziario | 13.91B |
| Unipol Assicurazioni | 13.85B |
| FinecoBank Banca Fineco | 13.47B |
| Moncler | 13.44B |
| Telecom Italia | 12.66B |
| Edison | 11.34B |
| Technoprobe | 10.20B |